Ocular penetration enhancers

Enhancement in Drug Delivery

Volumn , Issue , 2006, Pages 527-548

  Kaur, Indu Pal ^a   Batra, Anupam ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85046253077     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (124)

1. Raviola, G. 1977. The structural basis of blood ocular barriers. Exp Eye Res 25:27.
2. Stjernschantz, J., and M. Astin. 1993. Anatomy and physiology of the eye. Physiological aspects of ocular drug delivery. In Biopharmaceutics of Ocular Drug Delivery, ed. P. Edman, chap. 1. Boca Raton, FL: CRC Press.
3. Schoenwald, R.D. 1990. Ocular drug delivery. Pharmacokinetic considerations. Clin Pharmacokinet 18:155.
4. Aiache, J.M., et al. 1997. The formulation of drug for ocular administration. J Biomater Appl 11:329.
5. Mishima, S. 1965. Some physiological aspects of the precorneal tear film. Arch Ophthalmol 73:233.
6. Nicolaides, N., et al. 1981. Meibomian gland studies: Comparison of steer and human lipids. Invest Ophthalmol Vis Sci 20:522.
7. Gandhi, R.B., and J.R. Robinson. 1991. Permselective characteristics of rabbit buccal mucosa. Pharm Res 8:1199.
8. Mariott, C., and N.P. Gregory. 1990. Mucus physiology and pathology. In Bioadhesive Drug Delivery Systems, eds. Lenearts, V. and R. Gurney, chap 1. Boca Raton, FL: CRC Press.
9. Johnson, P.M., and K.D. Rainsford. 1972. The physical properties of mucus: Preliminary observations on the sedimentation behaviour of porcine gastric mucosa. Biochim Biophys Acta 286:72.
10. Milder, B. 1987. The lacrimal apparatus. In: Alder’s Physiology of the Eye, Clinical Application, eds. Moses, R.A. and W.M.J. Hart, 15. St. Louis: The C.V. Mosby Company.
11. Lamberts, D.W. 1987. Basic science aspects: physiology of the tear film. In The Cornea: Scientific Foundations and Clinical Practice, eds. Smoli, G. and R.A. Thoft, 16. Boston/Toronto: Little, Brown and Company.
12. Doane, M.G., A.D. Jense, and C.H. Dohlman. 1978. Penetration routes of topically applied medications. Am J Ophthalmol 85:383.
13. Watsky, M.A., M.M. Jablonski, and H.F. Edelhauser. 1988. Comparison of conjunctival and corneal surface areas in rabbit and human. Curr Eye Res 7:483.
14. Ahmed, I., et al. 1987. Physiochemical determinants of drug diffusion across the conjunctiva, sclera and cornea. J Pharm Sci 76:583.
15. Wang, W., et al. 1991. Lipophilicity influence on conjunctival drug penetration in pigmented rabbit: A comparison with corneal penetration. Curr Eye Res 10:571.
16. Reinsten, D.Z., et al. 1994. Epithelial and corneal thickness measurements by high frequency ultrasound digital signal processing. Ophthalmology 101:140.
17. Klyce, S.D., and C.E. Crosson. 1985. Transport processes across the rabbit corneal epithelium:A review. Curr Eye Res 4:323.
18. Barry, B.W. 1983. Percutaneous absorption. In Dermatological Formulations, ed. Barry, B.W., 127. Marcel Dekker.
19. Junginger, H.E., and J.C. Verhoef. 1998. Macromolecules as safe penetration enhancers for hydrophilic drugs-a fiction? Pharm Sci Technol Today 1:370.
20. Gumbiner, B. 1987. Structure, biochemistry and assembly of epithelial tight junctions. Am J Physiol 253:749.
21. Anderson, J.M., and C.M. Van Itallie. 1995. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269:467.
22. Shasby, D.M., M. Winter, and S. Shasby. 1988. Oxidants and conductance of cultured epithelial cell monolayers: Inositol phospholipid hydrolysis. Am J Physiol 255:781.
23. Mullin, J.M., and T.G. O’Brien. 1986. Effects of tumor promoters on LLC-PK1 renal epithelial tight junctions and transepithelial fluxes. Am J Physiol 251:597.
24. Rojanasakul, Y., and J.R. Robinson. 1991. The cytoskeleton of cornea and its role in tight junction permeability. Int J Pharm 68:135.
25. Muranishi, N., et al. 1981. Effect of fatty acids and monoglycerides on permeability of lipid bilayers. Chem Phys Lipids 28:269.
26. Tengamnuay, P., and A.K. Mitra. 1990. Bile-salt fatty acid mixed micelles as nasal absorption promoters of peptides. I. Effects of ionic strength, adjuvant composition and lipid structure on the nasal absorption of [D-Arg2]kyotorphin. Pharm Res 7:127.
27. Lichtenberg, D., R.J. Robson, and E.A. Dennis. 1983. Solubilization of phospholipids by detergents. Structural and kinetic aspects. Biochim Biophys Acta 737:285.
28. Nakanishi, K., et al. 1984. Mechanism of enhancement of rectal permeability of drugs by nonsteroidal anti-inflammatory drugs. Chem Pharm Bull 32:3187.
29. Martinez-Palomo, A., et al. 1980. Experimental modulation of occluding junctions in a cultured transporting epithelium. J Cell Biol 87:736.
30. Pitelka, D.R., B.N. Taggart, and S.T. Hamamotto. 1983. Effects of extracellular calcium depletion on membrane topography and occluding junctions of mammary epithelial cells in culture. J Cell Biol 96:613.
31. Saettone, M.F., et al. 1996. Evaluation of ocular permeation enhancers: In vitro effects on corneal transport of four b-blockers, and in vitro/in vivo toxic activity. Int J Pharm 142:103.
32. Hochman, J., and P.J. Artursson. 1994. Mechanisms of absorption enhancement and tight junction regulation. J Control Release 29:253.
33. Citi, S. 1992. Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells. J Cell Biol 117:169.
34. Volberg, T., et al. 1986. Changes in membrane microfilament interaction in intercellular adherens junctions upon removal of extracellular Ca2+ ions. J Cell Biol 102:1832.
35. Volk, T., and B. Geiger. 1986. A-CAM: A 135-KD receptor of intercellular adherens junctions. II. Antibody mediated modulation of junction formation. J Cell Biol 103:1451.
36. Grass, G.M., and J.R. Robinson. 1988. Mechanisms of corneal drug penetration I: In vivo and in vitro kinetics. J Pharm Sci 77:3.
37. Ashton, P., S.K. Podder, and V.H.L. Lee. 1991. Formulation influence on conjunctival penetration of four b-blockers in pigmented rabbit: A comparison with corneal penetration. Pharm Res 8:1166.
38. Ashton, P., W. Wang, and V.H.L. Lee. 1991. Location of penetration and metabolic barriers to levobunolol in the corneal epithelium of the pigmented rabbit. J Pharmacol Exp Ther 259:719.
39. Sasaki, H., et al. 1995. Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic b-blockers. J Pharm Res 12:1146.
40. Kaur, I.P., M. Singh, and M. Kanwar. 2000. Formulation and evaluation of ophthalmic preparations of acetazolamide. Int J Pharm 199:119.
41. van Hoogdalem, E.J., et al. 1989. Intestinal drug absorption enhancement: An overview. Pharmac Ther 44:407.
42. Hosoya, K., and V.H.L. Lee. 1997. Cidofovir transport in the pigmented rabbit conjunctiva. Curr Eye Res 16:693.
43. Hochman, J.H., J.A. Fix, and E.L. LeCluyre. 1994. In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine. J Pharmacol Exp Ther 269:813.
44. Anderberg, E.K., and P. Artursson. 1993. Epithelial transport of drugs in cell culture VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells. J Pharm Sci 82:392.
45. Grzeskowiak, E. 1998. Biopharmaceutical availability of sulphadicramide from ocular ointments in vitro. Eur J Pharm Sci 6:247.
46. Harmia, T., P. Speiser, and J. Kreuter. 1987. Nanoparticles as drug carriers in ophthalmology. Pharm Acta Helv 62:322.
47. Morgan, R.V. 1995. Delivery of systemic regular insulin via the ocular route in cats. J Ocul Pharmacol Ther 11:565.
48. O’Hagan, D.T., and L. Illum. 1990. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine. Crit Rev Ther Drug Carrier Syst 7:35.
49. Sakai, K., et al. 1986. Contribution of calcium ion sequestration by polyoxyethylated nonionic surfactants to the enhanced colonic absorption of p-aminobenzoic acid. J Pharm Sci 75:387.
50. Kaur, I.P., et al. 2004. Development of topically effective formulations of acetazolamide using HPb-CD-polymer co-complexes. Curr Drug Deliv 1:65.
51. Aggarwal, D., A. Garg, and I.P. Kaur. 2004. Development of a topical niosomal preparation of acetazolamide: Preparation and evaluation. J Pharm Pharmacol 56:1509.
52. Morimoto, K., T. Nakai, and K. Morisaka. 1987. Evaluaton of permeability enhancement of hydrophilic compounds and macromolecular compounds by bile salts through rabbit corneas in vitro. J Pharm Pharmacol 39:124.
53. Burstein, N.L. 1984. Preservative alteration of corneal permeability in humans and rabbits. Invest Ophthalmol Vis Sci 25:1453.
54. Lee, V.H., and J.R. Robinson. 1986. Topical ocular delivery: Recent developments and future challenges. J Ocul Pharmacol 2:67.
55. Camber, O., and P. Edman. 1987. Influence of some preservatives on the corneal permeability of pilocarpine and dexamethasone, in vitro. Int J Pharm 39:229.
56. Green, K. 1993. The effects of preservatives on corneal permeability of drugs. In Biopharmaceutics of Ocular Drug Delivery, ed. Edman, P., 43. Boca Raton, FL: CRC Press.
57. Higaki, K., M. Takeuchi, and M. Nakano. 1996. Estimation and enhancement of in vitro corneal transport of S-1033, a novel antiglaucoma medication. Int J Pharm 132:165.
58. Podder, S.K., K.C. Moy, and V.H. Lee. 1992. Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition. Exp Eye Res 54:747.
59. Smolen, V.F., et al. 1973. Biphasic availability of ophthalmic carbachol. I. Mechanisms of cationic polymer and surfactant promoted miotic activity. J Pharm Sci 62:958.
60. Burton, G.D., and R.M. Hill. 1981. Aerobic responses of the cornea to ophthalmic preservatives, measured in vivo. Invest Ophthalmol Vis Sci 21:842.
61. Pfister, R.R., and N. Burstein. 1976. The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: A scanning electron microscope study. Invest Ophthalmol 15:246.
62. Green, K., and A. Tonjum. 1971. Influence of various agents on corneal permeability. Am J Ophthalmol 72:897.
63. Green, K., and A.M. Tonjum. 1975. The effect of benzalkonium chloride on the electropotential of the rabbit cornea. Acta Ophthalmol 53:348.
64. Mikkelson, T.J., S.S. Chrai, and J.R. Robinson. 1973. Competitive inhibition of drug-protein interaction in eye fluids and tissues. J Pharm Sci 62:1942.
65. Godbey, R.E., K. Green, and D.S. Hull. 1989. Influence of cetylpyridinium chloride on corneal permeability to penicillin. J Pharm Sci 78:815.
66. Pillion, D.J., et al. 1996. Structure-function relationship among Quillaja saponins serving as excipients for nasal and ocular delivery of insulin. J Pharm Sci 85:518.
67. Chiou, G.C., and C.Y. Chuang. 1989. Improvement of systemic absorption of insulin through eyes with absorption enhancers. J Pharm Sci 78:815.
68. Fiscum, G. 1985. Intracellular levels and distribution of Ca2+ in digitonin-permeabilized cells. Cell Calcium 6:25.
69. Wolosin, J.M. 1988. Regeneration of resistance and ion transport in rabbit corneal epithelium after induced surface cell exfoliation. J Membr Biol 104:45.
70. Liaw, J., and J.R. Robinson. 1992. The effect of polyethylene glycol molecular weight on corneal transport and related influence of penetration enhancers. Int J Pharm 88:125.
71. Kato, A., and S. Iwata. 1988. In vitro study on corneal permeability to bunazosin. J Pharmacobiodyn 11:115.
72. Muranishi, S. 1990. Absorption enhancers. Crit Rev Ther Drug Carr Sys 7:1.
73. Kato, A., and S. Iwata. 1988. Studies on improved corneal permeability to bunazosin. J Pharmacobiodyn 11:330.
74. Newton, C., B.M. Gebhardt, and H.E. Kaufman. 1988. Topically applied cyclosporine in azone prolongs corneal allograft survival. Invest Ophthalmol Vis Sci 29:208.
75. Tang-Liu, D.D., et al. 1994. Effects of four penetration enhancers on corneal permeability of drugs in vitro. J Pharm Sci 83:85.
76. Artursson, et al. 1994. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 11:1358.
77. Illum, L., N.F. Farraj, and S.S. Davis. 1994. Chitosan as a novel nasal drug delivery system for peptide drugs. Pharm Res 11:1186.
78. Dodane, V., M.A. Khan, and J.R. Merwin. 1999. Effect of chitosan on epithelial permeability and structure. Int J Pharm 182:21.
79. Di Colo, G., et al. 2004. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin. Int J Pharm 273:37.
80. Burgalassi, S., et al. 2000. Effect of xyloglucan (tamarind seed polysaccharide) on conjunctiva cell adhesion to laminin and on corneal epithelium wound healing. Eur J Ophthalmol 10:71.
81. Ghelardi, E., et al. 2000. Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamycin and ofloxacin in rabbits. J Antimicrob Chemother 46:831.
82. Ghelardi, E., et al. 2004. A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis. Antimicrob Agents Chemother 48:3396.
83. Bijl, P., et al. 2001. Effects of three penetration enhancers on transcorneal permeation of cyclosporine. Cornea 20:505.
84. Flanagan, M.D., and S. Lin. 1980. Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J Biol Chem 255:835.
85. Brown, S.S., and J.A. Spudich. 1981. Mechanism of action of cytochalasin: Evidence that it binds to actin filament ends. J Cell Biol 88:487.
86. Craig, S.W., and J.V. Pardo. 1979. a-Actinin localization in the junctional complex of intestinal epithelial cells. J Cell Biol 80:203.
87. Meza, I., et al. 1980. Occluding junctions and cytoskeletal components in a cultured transporting epithelium. J Cell Biol 87:746.
88. Rojanasakul, Y., J. Liaw, and J.R. Robinson. 1990. Mechanisms of action of some penetration enhancers in the cornea: Laser scanning confocal microscopic and electrophysiology studies. Int J Pharm 66:131.
89. Mitra, A.K. 1983. PhD diss., University of Kansas, Lawrence, KS.
90. Pitelka, D.R., B.N. Taggart, and S.T. Hamamoto. 1983. Effects of extracellular calcium depletion on membrane topography and occluding junctions of mammary epithelial cells in culture. J Cell Biol 96:613.
91. Lehr, C.M., et al. 1992. Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat. J Pharm Pharmacol 44:402.
92. Borchard, G., et al. 1996. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan glutamate and carbomer on epithelial tight junctions in vitro. J Control Release 39:131.
93. Lehr, C.M., Y.H. Lee, and V.H. Lee. 1994. Improved ocular penetration of gentamycin by mucoadhesive polymer polycarbophil in the pigmented rabbit. Invest Ophthalmol Vis Sci 35:2809.
94. Hornof, M.D., and A.B. Schnurch. 2002. In vitro evaluation of the permeation enhancing effect of polycarbophil-cysteine conjugates on the cornea of rabbits. J Pharm Sci 91:2588.
95. Freedman, K.A., J.W. Klein, and C.E. Crosson. 1993. Beta-cyclodextrins enhance bioavailability of pilocarpine. Curr Eye Res 12:641.
96. Reer, O., T.K. Block, and B.W. Muller. 1994. In vitro corneal permeability of diclofenac sodium in formulations containing cyclodextrins compared to the commercial product Voltaren Ophtha. J Pharm Sci 83:1345.
97. Jarvinen, K., et al. 1994. The effect of modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine. Curr Eye Res 13:897.
98. Loftssona, T., and T. Jarvinen. 1999. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev 36:59.
99. Tirucherai, G.S., and A.K. Mitra. 2003. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of gancyclovir. AAPS Pharm Sci Tech 4:E45.
100. Aktas, Y. 2003. Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine. Drug Dev Ind Pharm 29:223.
101. Desai, S.D., and Blanchard, J. 1994. Ocular drug formulation and delivery, in Encyclopedia of Pharmaceutical Technology, vol. 3, eds. Swarbrick, J. and J.C. Boylan, 43. New York: Marcel Dekker.
102. Hayakawa, E., et al. 1992. Conjunctival penetration of insulin and peptide drugs in the albino rabbit. Pharm Res 9:769.
103. Pillion, D.J., et al. 1994. Efficacy of insulin eyedrops. J Ocul Pharmacol 10:461.
104. Yamamoto, A., et al. 1989. The ocular route for systemic insulin delivery in the albino rabbit. J Pharmacol Exp Ther 249:249.
105. Grass, G.M., R.W. Wood, and J.R. Robinson. 1985. Effects of calcium chelating agents on corneal permeability. Invest Ophthalmol Vis Sci 26:110.
106. Marsh, R.J., and D.M. Maurice. 1971. The influence of non-ionic detergents and other surfactants on human corneal permeability. Exp Eye Res 11:43.
107. Sasaki, H. 1994. Effect of preservatives on systemic delivery of insulin by ocular instillation in rabbits. J Pharm Pharmacol 46:871.
108. Grzeskowiak, E. 1998. Technology and biopharmaceutical availability of solid ocular inserts containing sulfadicramide and some promoters. Acta Pol Pharm 55:205.
109. Van Santvliet, L., and A. Ludwig. 1998. The influence of penetration enhancers on the volume instilled of eye drops. Eur J Pharm Biopharm 45:189.
110. Green, K., J.M. Chapman, and J.L. Cheeks, 1987. Ocular penetration of pilocarpine in rabbits. J Toxicol 2:89.
111. Grass, G.M., and J.R. Robinson. 1984. Relationship of chemical structure to corneal penetration and influence of low viscosity solution on ocular bioavailability. J Pharm Sci 73:1021.
112. Ismail, I.M., et al. 1992. Comparison of azone and hexamethylene lauramide in toxicologic effects and penetration enhancement of cimetidine in rabbit eyes. Pharm Res 9:817.
113. Merkus, F.W.H. M., et al. 1993. Absorption enhancers in nasal drug delivery: Efficacy and safety. J Control Release 24:201.
114. Draize, J.H., G. Woodard, and H.O. Calvery. 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377.
115. North-Root, H., et al. 1982. Evaluation of an in vitro cell toxicity test using rabbit corneal cells to predict the eye irritation potential of surfactants. Toxicol Lett 14:207.
116. Yang, W., and D. Acosta. 1994. Cytotoxicity potential of surfactant mixtures evaluated by primary cultures of rabbit corneal epithelial cells. Toxicol Lett 70:309.
117. Kruszewski, F.H., T.L. Walker, and L.C. DiPasquale. 1997. Evaluation of a human corneal epithelial cell line as an in vitro model for assessing ocular irritation. Fundam Appl Toxicol 36:130.
118. Parnigotto, P.P., et al. 1998. Bovine corneal stroma and epithelium reconstructed in vitro: Characterization and response to surfactants. Eye 12:304.
119. Saarinen-Savolainen, P., et al. 1998. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm Res 15:1275.
120. Burgalassi, S., et al. 2001. Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. Toxicol Lett 122:1.
121. Furrer, P., et al. 2000. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. Int J Pharm 207:89.
122. Monti, D., et al. 2002. Increased corneal hydration induced by potential ocular penetration enhancers: Assessment by differential scanning calorimetry (DSC) and by desiccation. Int J Pharm 232:139.
123. Rojanasakul, Y., J. Liaw, and J.R. Robinson. 1990. Mechanisms of action of some penetration enhancers in the cornea: Laser scanning confocal microscopic and electrophysiology studies. Int J Pharm 66:131.
124. Chetoni, P., et al. 2003. Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas. Toxicol In Vitro 17:197.